Opioids remain the mainstay of severe pain management in patients with cancer.

However, carefully controlled, large case-control studies will remain the mainstay in molecular genetic epidemiology.

Surgery, stereotactic radiosurgery and whole-brain radiotherapy with or without cytotoxic chemotherapy remain the mainstay of treatment.

Vaccines against these viruses are lacking; thus, infection control measures remain the mainstay for preventing nosocomial spread.

The number of manufacturing plants will doubtless increase, but agriculture is bound to remain the mainstay of the country.

Even with screening strategies, frequent monitoring of complete blood count and liver biochemistry should remain the mainstay of surveillance for azathioprine toxicity.

In the uncomplicated diverticulitis, outpatient management is considered the optimal approach in the majority of patients, and oral antibiotics remain the mainstay of treatment.

Results: En bloc resection remains the mainstay of therapy with curative intent.

Surgery remains the mainstay of treatment for early-stage non-small cell lung cancer.

Systemic chemotherapy remains the mainstay therapeutic option for this poor prognosis cancer.

Chemotherapy remains the mainstay in the treatment of multiple myeloma today.

Combination antiinflammatory and long-acting bronchodilator therapy remains the mainstay of management.

Resection remains the mainstay treatment for early-stage gastroesophageal neuroendocrine tumors.

To date, complete surgical resection remains the mainstay of treatment especially for earlier stage disease.

Conclusion: Complete surgery without rupture remains the mainstay of treatment in patients with localized, resectable disease.

Currently, surgical intervention remains the mainstay of therapy.